Valuation Catalyst Pharmaceuticals, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-01 EDT			5-day change	1st Jan Change
31.44 ^USD	+0.03%		+0.06%	+34.70%

07-01	Santhera Says Early Trial Backs Agamree for Chronic Inflammatory Rare Diseases	MT
07-01	Santhera Pharmaceuticals Notes Topline Results from Catalyst Pharmaceuticals Phase 1 Clinical Study of AGAMREE	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	698.1	1,936	1,792	2,489	2,869	3,848	-	-
Change	-	177.28%	-7.42%	38.9%	15.25%	34.12%	-	-
Enterprise Value (EV)	506.8	1,637	1,655	1,972	2,160	3,848	3,848	3,848
Change	-	223.05%	1.05%	19.17%	9.53%	78.16%	0%	0%
P/E	18.3x	24.8x	26.7x	15.9x	13.9x	16.1x	13.1x	12.2x
PBR	3.53x	6.9x	4.93x	3.47x	3x	-	-	-
PEG	-	0x	-1.7x	0x	0.5x	1x	0.6x	1.69x
Capitalization / Revenue	4.96x	9.04x	4.5x	5.06x	4.87x	6.05x	5.36x	4.86x
EV / Revenue	0x	0x	0x	0x	0x	6.05x	5.36x	4.86x
EV / EBITDA	-	-	-	0x	0x	10.6x	9.47x	8.99x
EV / EBIT	0x	0x	0x	0x	0x	12.1x	9.99x	9.32x
EV / FCF	0x	0x	0x	0x	0x	17.4x	14.2x	12.3x
FCF Yield	8.5%	5.99%	8%	9.61%	7.27%	5.74%	7.04%	8.16%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.37	0.75	0.63	1.31	1.68	1.953	2.407	2.58
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	140.8	214.2	398.2	491.7	589	636.2	717.9	792.2
EBITDA ¹	-	-	-	255.1	320.4	363.3	406.5	428
EBIT ¹	52.38	101.8	86.81	195.1	257.8	318	385.3	412.8
Net income ¹	39.48	83.08	71.41	163.9	214.3	231.1	316.2	320
Net Debt	-191.3	-298.4	-137.6	-517.6	-709.2	-	-	-
Reference price ²	6.77	18.60	16.81	20.87	23.34	31.44	31.44	31.44
Nbr of stocks (in thousands)	103,118	104,071	106,611	119,273	122,912	122,381	-	-
Announcement Date	3/16/22	3/15/23	2/28/24	2/26/25	2/25/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CATALYST PHARMACEUTICALS, INC.	16.1x	-	-	-.--%	3.85B
REGENERON PHARMACEUTICALS, INC.	16.17x	3.5x	9.45x	0.63%	63.56B
UCB	27.72x	5.64x	16.51x	0.57%	55.92B
SAMSUNG BIOLOGICS CO.,LTD.	34.62x	11.72x	22.19x	-.--%	41.68B
CSL LIMITED	-43.96x	3.12x	9.21x	3.49%	39.12B
BIOGEN INC.	33.87x	3.61x	11.1x	-.--%	30.97B
MODERNA, INC.	-8.4x	12.02x	-7.38x	-.--%	28.77B
INCYTE CORPORATION	16.52x	3.14x	9.5x	-.--%	22.74B
INNOVENT BIOLOGICS, INC.	50.1x	5.51x	37.82x	-.--%	17.64B
SWEDISH ORPHAN BIOVITRUM AB	25.89x	5.38x	14.42x	-.--%	16.66B
Average	16.86x	5.96x	13.65x	0.47%	32.09B
Weighted average by Cap.	15.15x	5.88x	12.82x	0.65%